PROQR THRAPEUTICS N V's ticker is PRQR and the CUSIP is N71542109. A total of 77 filers reported holding PROQR THRAPEUTICS N V in Q4 2021. The put-call ratio across all filers is 2.49 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $46,178 | -83.2% | 21,680 | -92.9% | 0.00% | -100.0% |
Q1 2022 | $275,000 | -90.0% | 303,356 | -11.3% | 0.00% | -85.7% |
Q4 2021 | $2,740,000 | -38.2% | 342,083 | -35.4% | 0.01% | -53.3% |
Q3 2021 | $4,435,000 | +12.3% | 529,883 | -9.5% | 0.03% | +20.0% |
Q2 2021 | $3,948,000 | – | 585,806 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
M28 Capital Management LP | 1,910,600 | $2,483,780 | 2.85% |
Privium Fund Management B.V. | 5,344,446 | $6,947,780 | 2.07% |
DAFNA Capital Management LLC | 940,582 | $1,222,757 | 0.38% |
Monaco Asset Management SAM | 377,517 | $490,772 | 0.15% |
EcoR1 Capital, LLC | 2,980,016 | $3,874,021 | 0.13% |
Ikarian Capital, LLC | 472,625 | $614,412 | 0.07% |
FRANKLIN STREET ADVISORS INC /NC | 150,000 | $195 | 0.02% |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 3,625,467 | $4,713,107 | 0.01% |
GSA CAPITAL PARTNERS LLP | 74,084 | $96 | 0.01% |
UBS OCONNOR LLC | 189,328 | $246,126 | 0.01% |